<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181108041594N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-04</date_registration>
      <primary_sponsor>Sabzevar University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effect of cool dialysate and stretching exercises on restless leg syndrome in dialysis patients</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effect of cool dialysate and stretching exercises on restless leg syndrome in patients undergoing hemodialysis with chronic renal failure</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-12-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/35130</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The samples are selected according to the eligibility criteria and then they randomly are assigned  in two groups with 30 patients, the stretching exercises group (by performing hemodialysis with dialysis solution temperature 37) and cold dialysate group (performing hemodialysis with dialysis solution 35/5) using the Permutation blocks method. The control group is marked with the letter a and the intervention group with the letter b and the size of each block is 4, and the number of blocks is 15 and the number of possible permutations is 4. Then from the random number table or using the simulation command in the application R (runif(15,min=1,max=4)، fifteen random numbers selected and fill 15 blocks of states.So the first four person who enter the study the first person receiving treatment b, the second treatment a, the third person receiving treatment b, and the fourth person receiving treatment a.second Four person who enter the study the first person receiving treatment b, the second treatment b, the third person receiving treatment a, and the fourth person receiving treatment a . Fifteenth four person  who enter the study the first person receiving treatment b, the second treatment a, the third person receiving treatment b, and the fourth person receiving treatment a. In this study Patients are not blind. The researcher will be blinded by completing the questionnaires by researcher assistant. And data analyzers will be blinded by patient encoding.
, Blinding description: In this study Patients are not blind.The researcher will be blinded by completing the questionnaires by researcher assistant. And data analyzers will be blinded by patient encoding.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Restless leg syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:Among patients with restless leg syndrome, a group of 30 patients is selected as the cold dialysis solution group. And they will undergo cold hemodialysyis (35.5 ° C ) 4 hours at each session, for 6 weeks. Intervention 2: Intervention group 2: Among patients with restless leg syndrome, 30 patients undergo stretching exercises and for 6 weeks 3 times a week for half an hour in the first 2 hours of dialysis, stretching exercises including pelvic to the sides, Quadriceps muscle stretching, stretching of the muscle of the gluteal muscle , Pulling the hamstrings and pulling the knee to the chest. The dialysis temperature for the group is the same as the standard solution temperature (37 ° C).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mostafa Rad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Block  B, Pardis of Sabzevar University of Medical Sciences, Road Tohid Shahr</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9613873119</zip>
        <telephone>+98 51 4401 8314</telephone>
        <email>mostafarad633@yahoo.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mostafa Rad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Block  B, Pardis of Sabzevar University of Medical Sciences, Road Tohid Shahr</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9613873119</zip>
        <telephone>+98 51 4401 8314</telephone>
        <email>mostafarad633@yahoo.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having informed consent to participate in the study
Age over 18 and up to 71 years
Patients with a minimum hemoglobin of 10 mg / dL
Patient diagnosed with chronic renal failure who has been undergoing hemodialysis for 3 months
Patients with arteriovenous fistula for hemodialysis
Patients undergoing hemodialysis three times a week and each session are 4 hours
Patients who have had Hemodialysis over the past 2 months have had a history of restless leg syndrome during Hemodialysis
Patients with adequacy of dialysis more or equal 1</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>71 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Hearing and visual impairment
Taking medication or food that exacerbates restless leg syndrome during dialysis
Pregnancy and the presence of liver problems
Receiving treatments that are effective on restless leg syndrome during dialysis (complementary medicine, acupuncture and topical conditioners)
The presence of any infection and ulcers in the legs
Having orthopedic problems
Having vascular problems in the lower extremities
Severe mental illness and mood disorder - severe emotional disturbance that prevents effective communication.
Patient with hypercalcemia and hypocalcemia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G25.81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Restless legs syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:Among patients with restless leg syndrome, a group of 30 patients is selected as the cold dialysis solution group. And they will undergo cold hemodialysyis (35.5 ° C ) 4 hours at each session, for 6 weeks.</i_keyword>
      <i_keyword>Intervention group 2: Among patients with restless leg syndrome, 30 patients undergo stretching exercises and for 6 weeks 3 times a week for half an hour in the first 2 hours of dialysis, stretching exercises including pelvic to the sides, Quadriceps muscle stretching, stretching of the muscle of the gluteal muscle , Pulling the hamstrings and pulling the knee to the chest. The dialysis temperature for the group is the same as the standard solution temperature (37 ° C).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Restless legs syndrome. Timepoint: The measurements of restless leg syndrome are at the beginning of the study before the start of the intervention and then at the end of each week after the completion of the dialysis for 6 weeks. Method of measurement: The severity of restless leg syndrome questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sabzevar University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-11-11</approval_date>
        <contact_name>Ethics Committee of Sabzevar University of Medical Sciences</contact_name>
        <contact_address>Block B, Pardis of Sabzevar University of Medical Sciences, Road Tohid Shahr Sabzevar Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
